Key Highlights
- Shares reached an annual peak of $23.10 on May 8, closing near $22.59 with approximately 437,000 shares traded
- A decade-long manufacturing partnership with Microchip Technology will establish U.S.-based MRAM production capacity in Oregon
- First quarter earnings showed $0.11 per share with $14.87M in revenue, surpassing the $14.60M forecast
- Second quarter 2026 earnings outlook ranges from $0.000 to $0.030 per share; analyst consensus remains at Hold with $18.50 average price target
- Executive leadership offloaded approximately $796K in shares during early May
Shares of Everspin Technologies (MRAM) touched a fresh 52-week peak of $23.10 during Friday trading on May 8, ultimately closing near $22.59. The current price substantially exceeds both the 50-day moving average at $11.18 and the 200-day moving average at $10.63.
Everspin Technologies, Inc., MRAM
Trading activity for the session reached approximately 437,000 shares, compared to the previous closing price of $21.51.
The semiconductor company has experienced roughly 25% appreciation recently, primarily fueled by a strategic manufacturing announcement made in April.
Strategic Partnership with Microchip Technology
Everspin revealed a 10-year collaboration with Microchip Technology on April 8 to manufacture MRAM and Tunnel Magnetoresistive (TMR) sensor products at Microchip’s fabrication plant in Oregon.
The arrangement preserves Everspin’s ownership of intellectual property and manufacturing processes. Additionally, the partnership introduces ITAR-compliant wafer processing capabilities, providing critical value for defense and aerospace applications.
Everspin plans to maintain operations at its current Chandler, Arizona facility alongside the new Oregon production line. Initial product shipments from the Oregon location are scheduled for the latter half of 2027.
The collaboration includes provisions for extension in two-year periods following the original 10-year commitment.
First Quarter Results Exceed Estimates While Second Quarter Outlook Remains Conservative
The company delivered Q1 2026 earnings of $0.11 per share alongside revenue of $14.87 million, topping analyst projections of $14.60 million.
Net profit margin registered at 0.50% while return on equity measured 4.78%.
Second quarter 2026 projections present a more subdued picture. Management issued earnings guidance spanning $0.000 to $0.030 per share — a notably broad and modest range indicating near-term uncertainty.
The company’s market capitalization currently stands at $593 million, accompanied by a PE ratio of 2,532 — illustrating the nascent stage of profitability development.
Analyst Ratings Show Mixed Sentiment While Insiders Reduce Positions
Wall Street perspectives remain divided. Needham elevated its price objective from $14.00 to $18.50 while reaffirming a Buy rating on April 30. Weiss Ratings maintained a Sell designation in March. Wall Street Zen adjusted its stance from Buy to Hold in February.
Overall analyst consensus points to Hold with an average price target of $18.50 — notably beneath current trading levels.
Regarding insider transactions, CEO Sanjeev Aggarwal divested 28,459 shares at $19.58 on May 4, generating approximately $557,000 in proceeds. This transaction decreased his holdings by 3.36%.
CFO William Earl Cooper sold 11,000 shares at $21.75 on May 6, amounting to $239,250 — representing a 6.39% reduction in his ownership position.
Combined insider selling activity totaled roughly 60,448 shares valued at approximately $990,000 throughout the previous three months.
Institutional investors hold 44.68% of outstanding shares, with multiple hedge funds establishing fresh positions during recent quarters, including Raymond James Financial, Kestra Advisory Services, and Occudo Quantitative Strategies.
The stock carries a beta of 1.75, indicating elevated volatility relative to broader market benchmarks.
